Jennison Associates
SLDB icon

Jennison Associates’s Solid Biosciences SLDB Stock Holding History

Jennison Associates’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-52,510
Closed -$21.1M – 682
2018
Q4 		$21.1M Buy
+52,510
New +$24.7M 0.02% 346
2018
Q2 		– Sell
-11,775
Closed -$1.32M – 706
2018
Q1 		$1.32M Buy
+11,775
New +$3.98M ﹤0.01% 545

Other funds holding SLDB

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Jennison Associates's SLDB Position: Q1 2019 in Review

Jennison Associates sold out of Solid Biosciences (SLDB) in Q1 2019, closing a stake of 52,510 shares — an estimated $21.1M sold.

Jennison Associates first reported a position in SLDB in Q1 2018 and held it in 2 quarters. The position peaked at $21.1M in Q4 2018. 74 funds tracked by Wall St. Rank hold SLDB as of Q1 2019.

  • Jennison Associates reported no remaining Solid Biosciences position as of Q1 2019 after selling out during the quarter.
  • Jennison Associates sold 52,510 Solid Biosciences shares in Q1 2019, an estimated $21.1M.
  • Jennison Associates first reported a position in Solid Biosciences in Q1 2018 and held it in 2 quarters.
  • Jennison Associates's Solid Biosciences position peaked at $21.1M in Q4 2018.
  • 74 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2019.

Based on Jennison Associates's 13F filing for Q1 2019, filed 10 May 2019.